EPISODE · Nov 8, 2023 · 15 MIN
Key strategies for global pharma companies to reduce risk and drive growth in the China market
from PwC's Next in Health
Tune in to hear PwC specialists discuss their recently published article: How a local-first strategy in China can help global pharma and life sciences players reduce risk and drive growth. Topics include:Sharing key strategies for pharma companies contemplating localization in China, offering valuable insights on maximizing business growth while mitigating risks in the Chinese marketThree approaches organizations can consider to competing at a local level in ChinaImpacts to different functions across the value chain such as R&D, supply chain, and ITSpeakers:Nalneesh Gaur, Partner, Pharmaceutical and Life Sciences Cybersecurity, PwC Ben Rhee, Principal, Pharmaceutical and Life Sciences Enterprise Strategy and Value, PwCIgor Belokrinitsky, Strategy& Principal, PwC For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
NOW PLAYING
Key strategies for global pharma companies to reduce risk and drive growth in the China market
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m